Recombinant Human DcR3/TNFRSF6B Fc Chimera, CF

• Supplier: R&D Systems
• Catalog: 142-DC-100
• Category: Protein
• Nature: Recombinant
• Source: Spodoptera frugiperda, Sf 21 (baculovirus)-derived
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: O95407
• Gene: TNFRSF6B

Product References

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates - DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates

Connor JP, Felder M, Kapur A, Onujiogu N. BMC Cancer. 2012 May 14;12:176.

Creation of a LIGHT mutant with the capacity to evade the decoy receptor for - Creation of a LIGHT mutant with the capacity to evade the decoy receptor for

Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Tsunoda S, Tsutsumi Y, Mukai Y, Okada N, Nakagawa S. Biomaterials. 2010 Apr;31(12):3357-63.

Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic - Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic

Tso GH, Law HK, Tu W, Chan GC, Lau YL. Stem Cells. 2010 May;28(5):939-54.

The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is - The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is

Mueller AM, Pedre X, Killian S, David M, Steinbrecher A. J Neuroimmunol. 2009 Apr 30;209(1-2):57-64.

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from - Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from

Colucci S, Brunetti G, Mori G, Oranger A, Centonze M, Mori C, Cantatore FP, Tamma R, Rizzi R, Liso V, Zallone A, Grano M. Leukemia. 2009 Nov;23(11):2139-46.

Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand - Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand

Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, Mizoguchi T, Sato M, Mogi M, Penninger JM, Takahashi N. J Immunol. 2007 Jan 1;178(1):192-200.

LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid - LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid

Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A. Arthritis Rheum. 2006 May;54(5):1451-62.